Letter from the Editor-in-Chief

Dear Colleagues,





The first two years of the Journal of Contemporary Brachytherapy are behind us. They brought us a great pleasure but also were a great challenge for the editors and members of editorial board because of relatively few radiotherapists in the world devoting his time to brachytherapy. It seems that this journal essentially improved possibility to present knowledge and achievements in the field of brachytherapy. Growing from the beginning, 69 scientists from 27 countries nowadays lead the Journal! In 2009 we have published 30 papers, in 2010 – 25, most of them were original papers. The reviewing process is constantly improved.

In the coming year of 2011 the JCB will be issued 4 times on paper and in electronic form, as it was in 2009 and 2010. In last year the Editorial Office along with the Publisher have started the process of indexing JCB. Now the Journal is indexed in Scopus, Index Copernicus, EMBASE (Excerpta Medica), Polish Medical Library (GBL), Directory of Open Access Journals (DOAJ). We wait for answers from Sci-Finder and ProQuest base. And in December 2010 we send the notification to PubMed Central.

Next planned index is Science Citation Index Expanded (SciSearch). Indexes from so called Philadelphia list (PubMed, Index Medicus/MEDLINE, Current Contents, etc.) and Journal Citation Reports/Science Edition are very important in journal indexing but we must go through all the stages. In order to achieve next steps, we urgently require good, original papers of international origin and numerous citations in other papers. Please cite JCB articles in your papers. Not only clinical papers but also review papers, case reports, technical notes – are welcome.

Next year most of us will come to London, for GEC-ESTRO Meeting (07-12.05.2011). It will be a very special Meeting, connected with ESTRO 30th Anniversary. I think that it will be a good possibility to meet together as Editors and Editorial Board of JCB. We will discuss about improvement of our Journal and proposed detailed themes: contents, profiles, publishing house, finances, distribution, advertisement politics, cooperation with GEC-ESTRO, etc.

And finally some news from brachytherapy. Clinicians at Beaumont Hospital in Detroit, Michigan, have initiated a study of single-dose HDR brachytherapy in the treatment of men with low- and intermediate-risk, localized prostate cancer...


View full text...